The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A propensity score matching analysis

OBJECTIVES: To evaluate the detection rate of clinically significant prostate cancer (csPCa) in Magnetic resonance imaging and ultrasonography (MRI/US) fusion biopsy in patients with biopsy-naïve men for varying prostate-specific antigen (PSA) levels. Since MRI can efficiently detect csPCa compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Hye J., Shin, Teak J., Jung, Wonho, Ha, Ji Y., Kim, Byung H., Kim, Young H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042765/
https://www.ncbi.nlm.nih.gov/pubmed/35510102
http://dx.doi.org/10.1016/j.prnil.2021.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042765/
https://www.ncbi.nlm.nih.gov/pubmed/35510102
http://dx.doi.org/10.1016/j.prnil.2021.10.002

Ejemplares similares